PHAXIAM Therapeutics S.A. (PHXM) — Net Asset Quality Index
PHAXIAM Therapeutics S.A. (PHXM) has a Net Asset Quality Index of 39.5% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €39.11 Million minus total liabilities of €23.66 Million yields net assets of €15.45 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check PHXM asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
PHAXIAM Therapeutics S.A. Net Asset Quality Index Over Time (2010–2023)
This chart shows how PHAXIAM Therapeutics S.A.'s Net Asset Quality Index has evolved across 14 annual periods from 2010 to 2023. As of June 2024, the index stands at 39.5%, representing net assets of €15.45 Million against total assets of €39.11 Million EUR. See how liquid is PHAXIAM Therapeutics S.A.'s working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for PHAXIAM Therapeutics S.A. (2010–2023)
The table below presents the year-by-year Net Asset Quality Index for PHAXIAM Therapeutics S.A. from 2010 to 2023, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see PHXM market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 49.9% | €25.61 Million | €51.31 Million | €25.70 Million | ▼ -1.4 pp |
| 2022 | 51.3% | €23.49 Million | €45.81 Million | €22.32 Million | ▲ +17.1 pp |
| 2021 | 34.2% | €22.84 Million | €66.77 Million | €43.92 Million | ▲ +1.2 pp |
| 2020 | 33.0% | €26.54 Million | €80.40 Million | €53.86 Million | ▼ -39.2 pp |
| 2019 | 72.2% | €85.56 Million | €118.55 Million | €32.99 Million | ▼ -14.6 pp |
| 2018 | 86.8% | €145.60 Million | €167.84 Million | €22.24 Million | ▼ -6.2 pp |
| 2017 | 92.9% | €181.42 Million | €195.26 Million | €13.84 Million | ▲ +13.7 pp |
| 2016 | 79.3% | €35.64 Million | €44.97 Million | €9.33 Million | ▼ -9.7 pp |
| 2015 | 88.9% | €47.13 Million | €53.00 Million | €5.87 Million | ▲ +0.7 pp |
| 2014 | 88.2% | €35.82 Million | €40.61 Million | €4.78 Million | ▲ +12.5 pp |
| 2013 | 75.7% | €13.59 Million | €17.95 Million | €4.36 Million | ▲ +115.4 pp |
| 2012 | -39.7% | €-4.03 Million | €10.14 Million | €14.17 Million | ▼ -1.1 pp |
| 2011 | -38.6% | €-1.91 Million | €4.94 Million | €6.85 Million | ▼ -99.3 pp |
| 2010 | 60.7% | €3.99 Million | €6.56 Million | €2.58 Million | — |